Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 17, 2023
Lonza has completed its planned expansion of the bioconjugation facility in Visp (CH). The expansion includes two new manufacturing suites and supporting infrastructure to accommodate a wider range of customers, including companies entering clinical ...
read more
Camargo Pharmaceutical Services has received a significant growth investment from a private non-institutional investment firm.
read more
Akorn, Inc. and Hi-Tech Pharmacal Co., Inc. today announced that they have entered into a definitive agreement under which Akorn will acquire Hi-Tech for $640 million in cash.
read more
Wednesday, February 24, 2016
Deceleration of the pharmaceutical patent cliff, combined with expectations of a patent 'slope' for biologics, will support innovative drug manufacturers' U.S. sales, according to the first report in Fitch Ratings' 'Navigating the Pharmaceutical ...
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
Tuesday, October 27, 2020
PAO Group has executed a master services agreement with a clinical research organization in the U.S. to prepare PAOG for initiating an IND with the FDA.
read more
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ...
read more
Wednesday, January 04, 2017
Aptuit and Chiesi Farmaceutici have entered an agreement under which Aptuit will conduct an integrated Discovery Project aimed at providing innovative drugs to treat Idiopathic Pulmonary Fibrosis.
read more
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 myeloid checkpoint mechanism, today announced the change of the Company’s name to ALX Oncology. The new name and logo will differentiate ALX Oncology ...
read more
Heat Biologics, Inc. has unveiled enhanced allogeneic cell therapy manufacturing capabilities through its Scorpion Biological Services subsidiary.
read more
Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer ...
read more
Thursday, November 07, 2024
Compliance Group announced a new services partnership with Veeva Systems. Key service areas are Implementation, Validation and Post-Implementation Support Services including Release Management, 24/7 Support and Organizational Change Management (OCM).
read more
HitGen has extended and expanded its agreement with Merck into a multi-year research collaboration and license agreement to build and screen novel DNA-encoded libraries.
read more
Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, announced a transformative collaboration with Tasso Inc., a pioneer in clinical-grade, at-home, patient-centered blood testing, to develop...
read more
The Pharma & Biopharma Outsourcing Association (PBOA) praises Representatives Leonard Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA SOS Act (H.R. 1078). The Act would exempt privately-paid user fees ...
read more